Our data implicating ZCCHC6 as a regulator of γ-globin mRNA stabilization suggests that ZCCHC6 may be a target worth testing further as a therapeutic strategy for enhancing γ-globin expression in hemoglobinopathies. The gene discussed is TUT7; the disease is hemoglobinopathy.